BDBM559769 2-((4-(6-((4-cyano-2-fluorobenzyl)oxy)pyridin-2-yl)piperidin-1-yl)methyl)-4-fluoro-1-(2-methoxyethyl)-5-(phenylamino)-1H-benzo[d]imidazole-6-carboxylic acid Example 2.2-((4-(6-((4-carbamoyl-2-fluorobenzyl)oxy)pyridin-2-yl)piperidin-1-yl)methyl)-4-fluoro-1-(2-methoxyethyl)-5-(phenylamino)-1H-benzo[d]imidazole-6-carboxylic acid::WO2022109182, Example 1

SMILES COCCn1c(CN2CCC(CC2)c2cccc(OCc3ccc(cc3F)C#N)n2)nc2c(F)c(Nc3ccccc3)c(cc12)C(O)=O

InChI Key InChIKey=XUJMJBXVONXWCO-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 559769   

TargetGlucagon-like peptide 1 receptor(Human)
Gilead Sciences

WIPO
LigandPNGBDBM559769(2-((4-(6-((4-cyano-2-fluorobenzyl)oxy)pyridin-2-yl...)
Affinity DataIC50: 15nMAssay Description:GLP-1R activation by small molecule agonists is quantified by measuring cAMP increase in CHO cells stably expressing GLP-1R (MultiSpan product # C126...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
WIPO WO2022109182